{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:37:57Z","timestamp":1791974277326,"version":"4.4.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["0003\/COVI\/20"],"award-info":[{"award-number":["0003\/COVI\/20"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["20859\/PI\/18"],"award-info":[{"award-number":["20859\/PI\/18"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["21081\/PDC\/19"],"award-info":[{"award-number":["21081\/PDC\/19"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["PCT\/EP2020\/056729"],"award-info":[{"award-number":["PCT\/EP2020\/056729"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["FJC2018-036217-I"],"award-info":[{"award-number":["FJC2018-036217-I"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["PID2020-116709RB-I00"],"award-info":[{"award-number":["PID2020-116709RB-I00"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["CR 32774874"],"award-info":[{"award-number":["CR 32774874"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["965196"],"award-info":[{"award-number":["965196"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2019-PoC 899636"],"award-info":[{"award-number":["ERC-2019-PoC 899636"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019992","name":"Glenmark Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.plipres.2022.101182","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T19:51:17Z","timestamp":1658778677000},"page":"101182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome"],"prefix":"10.1016","volume":"87","author":[{"given":"Malvina","family":"Pizzuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Pelegrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Ruysschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plipres.2022.101182_bb0005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Mayor","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0015","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0020","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0025","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molmed.2016.12.007","article-title":"Inflammasome priming in sterile inflammatory disease","volume":"23","author":"Patel","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.plipres.2022.101182_bb0035","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00026.2016","article-title":"Posttranslational modification as a critical determinant of cytoplasmic innate immune recognition","volume":"97","author":"Baker","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.plipres.2022.101182_bb0040","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/j.cell.2021.11.011","article-title":"NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation","volume":"184","author":"Andreeva","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.plipres.2022.101182_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0050","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.1139111","article-title":"Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa","volume":"316","author":"Ohto","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.plipres.2022.101182_bb0055","doi-asserted-by":"crossref","first-page":"e2984","DOI":"10.1038\/cddis.2017.390","article-title":"Lytic cell death induced by melittin bypasses pyroptosis but induces NLRP3 inflammasome activation and IL-1\u03b2 release","volume":"8","author":"Mart\u00edn-S\u00e1nchez","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.plipres.2022.101182_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf4468","article-title":"Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation","volume":"7","author":"Tapia-Abell\u00e1n","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.plipres.2022.101182_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.immuni.2018.04.032","article-title":"The TWIK2 potassium Efflux Channel in macrophages mediates NLRP3 Inflammasome-induced inflammation","volume":"49","author":"Di","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.plipres.2022.101182_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114385","article-title":"P2X7 receptor and the NLRP3 inflammasome: partners in crime","volume":"187","author":"Pelegrin","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plipres.2022.101182_bb0075","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K+ efflux is the common trigger of NLRP3 Inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Mu\u00f1oz-Planillo","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.plipres.2022.101182_bb0080","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K + efflux-independent NLRP3 Inflammasome activation by small molecules targeting mitochondria","volume":"45","author":"Gro\u00df","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.plipres.2022.101182_bb0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-018-0761-3","article-title":"PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation","volume":"564","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0090","first-page":"369","article-title":"HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation","volume":"2020","author":"Magupalli","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.plipres.2022.101182_bb0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0105","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.20172222","article-title":"Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity","volume":"215","author":"Boucher","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.plipres.2022.101182_bb0110","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent Inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"issue":"369","key":"10.1016\/j.plipres.2022.101182_bb0115","article-title":"HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation","volume":"2020","author":"Magupalli","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.plipres.2022.101182_bb0120","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20151790","article-title":"A single domain antibody fragment that recognizes the adaptor ASC defines the role of ASC domains in inflammasome assembly","volume":"213","author":"Schmidt","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.plipres.2022.101182_bb0125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-021-03478-3","article-title":"Gasdermin D pore structure reveals preferential release of mature interleukin-1","volume":"593","author":"Xia","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.immuni.2017.11.013","article-title":"The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages","volume":"48","author":"Evavold","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.plipres.2022.101182_bb0135","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.aar7607","article-title":"ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation","volume":"362","author":"R\u00fchl","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.plipres.2022.101182_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","article-title":"The gasdermins, a protein family executing cell death and inflammation","volume":"20","author":"Broz","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0145","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","article-title":"Structural mechanism for GSDMD targeting by autoprocessed caspases in Pyroptosis","volume":"180","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.plipres.2022.101182_bb0150","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1073\/pnas.1607769113","article-title":"GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes","volume":"113","author":"Aglietti","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.plipres.2022.101182_bb0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-021-03218-7","article-title":"NINJ1 mediates plasma membrane rupture during lytic cell death","volume":"591","author":"Kayagaki","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0160","first-page":"1","article-title":"Gasdermins mediate cellular release of mitochondrial DNA during pyroptosis and apoptosis","volume":"35","author":"Torre-Minguela","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.plipres.2022.101182_bb0165","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni.2919","article-title":"The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response","volume":"15","author":"Baroja-Mazo","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0170","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/ni.2913","article-title":"The adaptor ASC has extracellular and \u201cprionoid\u201d activities that propagate inflammation","volume":"15","author":"Franklin","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0175","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1126\/science.aaf3036","article-title":"An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells","volume":"352","author":"Zanoni","year":"2016","journal-title":"Science (New York, N.Y.)"},{"issue":"341","key":"10.1016\/j.plipres.2022.101182_bb0180","first-page":"1246","article-title":"Noncanonical inflammasome activation by intracellular LPS independent of TLR4","volume":"2013","author":"Kayagaki","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.plipres.2022.101182_bb0185","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/eji.201545523","article-title":"Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells","volume":"45","author":"Schmid-Burgk","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0190","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1002\/eji.201545655","article-title":"NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5","volume":"45","author":"Baker","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0200","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41590-021-00869-6","article-title":"Inflammasomes and adaptive immune responses","volume":"22","author":"Deets","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","article-title":"Diverging inflammasome signals in tumorigenesis and potential targeting","volume":"19","author":"Karki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.plipres.2022.101182_bb0215","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.3390\/cancers13102297","article-title":"Targeting the NLRP3 inflammasome as a new therapeutic option for overcoming cancer","volume":"Vol 13","author":"Missiroli","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.plipres.2022.101182_bb0220","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.plipres.2022.101182_bb0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0230","first-page":"43","article-title":"Mesa del Castillo P, Pelegr\u00edn P. the NLRP3 and pyrin Inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Frontiers in","volume":"8","author":"de Torre-Minguela","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.plipres.2022.101182_bb0235","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.plipres.2022.101182_bb0240","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/art.39770","article-title":"Late onset cryopyrin-associated periodic syndrome due to myeloid-restricted somatic NLRP3 mosaicism","volume":"68","author":"Mensa-Vilaro","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.plipres.2022.101182_bb0245","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaci.2019.05.034","article-title":"A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: therapeutic efficacy of proton pump inhibitors","volume":"145","author":"Bertoni","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0250","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2009.05.005","article-title":"Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity","volume":"30","author":"Brydges","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.plipres.2022.101182_bb0255","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.immuni.2009.04.012","article-title":"A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses","volume":"30","author":"Meng","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.plipres.2022.101182_bb0260","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.plipres.2022.101182_bb0265","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","article-title":"Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the Oral NLRP3 inhibitor Dapansutrile in subjects with NYHA II-III systolic heart failure","volume":"77","author":"Wohlford","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.plipres.2022.101182_bb0270","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coph.2019.02.004","article-title":"Purinergic receptors and the inflammatory response mediated by lipids","volume":"47","author":"Alarc\u00f3n-Vila","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.plipres.2022.101182_bb0275","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrm2335","article-title":"Lipid signalling in disease","volume":"9","author":"Wymann","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.plipres.2022.101182_bb0280","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.4049\/jimmunol.1701723","article-title":"Cutting edge: mitochondrial assembly of the NLRP3 Inflammasome complex is initiated at priming","volume":"200","author":"Elliott","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0285","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121353119","article-title":"Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation","volume":"119","author":"Ohto","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.plipres.2022.101182_bb0290","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1083\/jcb.201709057","article-title":"Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation","volume":"217","author":"de la Roche","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.plipres.2022.101182_bb0295","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.bbamem.2015.03.014","article-title":"Role of lipid microdomains in TLR-mediated signalling","volume":"1848","author":"Ruysschaert","year":"2015","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.plipres.2022.101182_bb0300","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3390\/molecules26061704","article-title":"Techniques to study Inflammasome activation and inhibition by small molecules","volume":"26","author":"Angosto-Bazarra","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.plipres.2022.101182_bb0305","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jnc.13138","article-title":"Immune dysfunction in Niemann-pick disease type C","volume":"136","author":"Platt","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.plipres.2022.101182_bb0310","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","article-title":"Mitochondrial cardiolipin is required for NLRP3 inflammasome activation","volume":"39","author":"Iyer","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.plipres.2022.101182_bb0315","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.tcb.2020.09.004","article-title":"Cardiolipin in immune signaling and cell death","volume":"30","author":"Pizzuto","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.plipres.2022.101182_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf4468","article-title":"Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation","volume":"7","author":"Tapia-Abell\u00e1n","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.plipres.2022.101182_bb0325","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1194\/jlr.R800074-JLR200","article-title":"The role of oxidized phospholipids in atherosclerosis","volume":"50","author":"Berliner","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plipres.2022.101182_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12072021","article-title":"Impact of cholesterol metabolism in immune cell function and atherosclerosis","volume":"12","author":"Aguilar-Ballester","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.plipres.2022.101182_bb0335","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3389\/fimmu.2019.02927","article-title":"Lysophosphatidylcholine induces NLRP3 inflammasome-mediated foam cell formation and pyroptosis in human monocytes and endothelial cells","volume":"10","author":"Corr\u00eaa","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0340","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11926-012-0313-z","article-title":"Cholesterol crystals and inflammation","volume":"15","author":"Grebe","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.plipres.2022.101182_bb0345","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0350","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1126\/science.aaf3036","article-title":"An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells","volume":"352","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.plipres.2022.101182_bb0355","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41467-018-03409-3","article-title":"The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages","volume":"9","author":"Chu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.plipres.2022.101182_bb0360","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20031763","article-title":"Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory","volume":"200","author":"Chang","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.plipres.2022.101182_bb0365","doi-asserted-by":"crossref","first-page":"38503","DOI":"10.1074\/jbc.M203318200","article-title":"Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36","volume":"277","author":"Podrez","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plipres.2022.101182_bb0370","doi-asserted-by":"crossref","first-page":"24787","DOI":"10.1074\/jbc.274.35.24787","article-title":"Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein","volume":"274","author":"Watson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plipres.2022.101182_bb0375","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","article-title":"Human monocytes engage an alternative Inflammasome pathway","volume":"44","author":"Gaidt","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.plipres.2022.101182_bb0380","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1189\/jlb.3VMA1215-579RR","article-title":"Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages","volume":"101","author":"Yeon","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.plipres.2022.101182_bb0385","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.4049\/jimmunol.0903594","article-title":"Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation","volume":"185","author":"Oskolkova","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0390","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0021-9150(97)00295-5","article-title":"Lysophosphatidylcholine induces the production of IL-1\u03b2 by human monocytes","volume":"137","author":"Liu-Wu","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2022.101182_bb0395","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.4049\/jimmunol.177.12.8560","article-title":"Lysophosphatidylcholine stimulates IL-1\u03b2 release from microglia via a P2X 7 receptor-independent mechanism","volume":"177","author":"Stock","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 Inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2022.101182_bb0405","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8893305","article-title":"Multiple roles of 25-hydroxycholesterol in lipid metabolism, antivirus process, inflammatory response, and cell survival","volume":"2020","author":"Cao","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.plipres.2022.101182_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13129","article-title":"25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome","volume":"7","author":"Jang","year":"2016","journal-title":"Nat. Commun."},{"issue":"345","key":"10.1016\/j.plipres.2022.101182_bb0415","first-page":"679","article-title":"25-hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon","volume":"2014","author":"Reboldi","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.plipres.2022.101182_bb0420","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1157\/13123996","article-title":"Obesity, metabolic syndrome and diabetes: cardiovascular implications and therapy","volume":"61","author":"Alegr\u00eda Ezquerra","year":"2008","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.plipres.2022.101182_bb0425","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.plipres.2022.101182_bb0430","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/eji.201142079","article-title":"Sphingosine regulates the NLRP3-inflammasome and IL-1\u03b2 release from macrophages","volume":"42","author":"Luheshi","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0435","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","article-title":"Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 Inflammasome activation","volume":"38","author":"Yan","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.plipres.2022.101182_bb0440","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1194\/jlr.M037861","article-title":"Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes\/macrophages","volume":"54","author":"L\u2019homme","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plipres.2022.101182_bb0445","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbalip.2019.04.001","article-title":"Saturated fatty acids induce NLRP3 activation in human macrophages through K + efflux resulting from phospholipid saturation and Na, K-ATPase disruption","volume":"1864","author":"Gianfrancesco","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.plipres.2022.101182_bb0450","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/ATVBAHA.117.310581","article-title":"Saturated fatty acids undergo intracellular crystallization and activate the NLRP3 Inflammasome in macrophages","volume":"38","author":"Karasawa","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.plipres.2022.101182_bb0455","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid\u2013induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0460","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.celrep.2018.12.047","article-title":"Leishmania lipophosphoglycan triggers Caspase-11 and the non-canonical activation of the NLRP3 inflammasome","volume":"26","author":"de Carvalho","year":"2019","journal-title":"Cell Rep."},{"issue":"339","key":"10.1016\/j.plipres.2022.101182_bb0465","first-page":"975","article-title":"Caspase-11 protects against bacteria that escape the vacuole","volume":"2013","author":"Aachoui","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.plipres.2022.101182_bb0470","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798089","article-title":"LPS targets host guanylate-binding proteins to the bacterial outer membrane for non-canonical inflammasome activation","volume":"37","author":"Santos","year":"2018","journal-title":"EMBO J."},{"issue":"341","key":"10.1016\/j.plipres.2022.101182_bb0475","first-page":"1250","article-title":"Cytoplasmic LPS activates Caspase-11: implications in TLR4-independent endotoxic shock","volume":"2013","author":"Hagar","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.plipres.2022.101182_bb0480","first-page":"1","article-title":"The endotoxin delivery protein HMGB1 mediates Caspase-11-dependent lethality in Sepsis","volume":"0","author":"Deng","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.plipres.2022.101182_bb0485","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/JLB.4MR0118-038R","article-title":"Sensing of invading pathogens by GBPs: at the crossroads between cell-autonomous and innate immunity","volume":"104","author":"Santos","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.plipres.2022.101182_bb0490","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature13157","article-title":"Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases","volume":"509","author":"Meunier","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2022.101182_bb0495","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02682-y","article-title":"Human caspase-4 detects tetra-acylated LPS and cytosolic Francisella and functions differently from murine caspase-11","volume":"9","author":"Lagrange","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.plipres.2022.101182_bb0500","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.biochem.76.060305.151318","article-title":"Structure and function of {Toll} receptors and their ligands","volume":"76","author":"Gay","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.plipres.2022.101182_bb0505","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16889-z","article-title":"Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria","volume":"11","author":"Santos","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.plipres.2022.101182_bb0510","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41590-020-0697-2","article-title":"Guanylate-binding proteins convert cytosolic bacteria into caspase-4 signaling platforms","volume":"21","author":"Wandel","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101612","article-title":"A rapid Caspase-11 response induced by IFN\u03b3 priming is independent of guanylate binding proteins","volume":"23","author":"Brubaker","year":"2020","journal-title":"IScience"},{"key":"10.1016\/j.plipres.2022.101182_bb0520","article-title":"Ornithine lipid activates both TLR4 and the non-canonical NLRP3 Inflammasome","author":"Pizzuto","year":"2022","journal-title":"BioRxiv"},{"key":"10.1016\/j.plipres.2022.101182_bb0525","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1111\/1462-2920.14430","article-title":"Bacterial ornithine lipid, a surrogate membrane lipid under phosphate-limiting conditions, plays important roles in bacterial persistence and interaction with host","volume":"20","author":"Kim","year":"2018","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.plipres.2022.101182_bb0530","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1099\/mic.0.000607","article-title":"Accumulation of ornithine lipids in Vibrio cholerae under phosphate deprivation is dependent on VC0489 (OlsF) and PhoBR system","volume":"164","author":"Barbosa","year":"2018","journal-title":"Microbiol. (U. K.)"},{"key":"10.1016\/j.plipres.2022.101182_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2012.02623.x","article-title":"Ornithine lipids and their structural modifications: from A to E and beyond","volume":"335","author":"Vences-Guzm\u00e1n","year":"2012","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.plipres.2022.101182_bb0540","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fmolb.2020.610932","article-title":"Ornithine lipids in Burkholderia spp. Pathogenicity","volume":"7","author":"C\u00f3rdoba-Castro","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.plipres.2022.101182_bb0545","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1248\/bpb.31.1952","article-title":"The preparation of a lipidic endotoxin affects its biological activities","volume":"31","author":"Okemoto","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.plipres.2022.101182_bb0550","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1128\/iai.57.7.2086-2091.1989","article-title":"Macrophage activation by an ornithine-containing lipid or a serine-containing lipid","volume":"57","author":"Kawai","year":"1989","journal-title":"Infect. Immun."},{"key":"10.1016\/j.plipres.2022.101182_bb0555","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/iai.59.8.2560-2566.1991","article-title":"Protection of mice from lethal endotoxemia by use of an ornithine-containing lipid or a serine-containing lipid","volume":"59","author":"Kawai","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.plipres.2022.101182_bb0560","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.plipres.2008.03.002","article-title":"Cationic liposomal lipids: from gene carriers to cell signaling","volume":"47","author":"Lonez","year":"2008","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.plipres.2022.101182_bb0565","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","article-title":"Lipid nanoparticle technology for therapeutic gene regulation in the liver","volume":"159","author":"Witzigmann","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.plipres.2022.101182_bb0570","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection: a highly efficient, lipid-mediated {DNA}-transfection procedure","volume":"84","author":"Felgner","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.plipres.2022.101182_bb0575","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.plipres.2022.101182_bb0580","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/eji.1830271207","article-title":"Human immunodeficiency virus type-1-specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine","volume":"27","author":"S S, J F, H A, KI K, K H, N I","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0585","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ymthe.2004.12.024","article-title":"Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic lipid DiC14-amidine prevents allergic responses to house dust mite","volume":"11","author":"Jacquet","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.plipres.2022.101182_bb0590","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.vaccine.2011.10.071","article-title":"The cationic lipid, diC14 amidine, extends the adjuvant properties of aluminum salts through a TLR-4- and caspase-1-independent mechanism","volume":"30","author":"Wilmar","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.plipres.2022.101182_bb0595","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.plipres.2022.101182_bb0600","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2016.12.029","article-title":"Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers","volume":"247","author":"Pizzuto","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.plipres.2022.101182_bb0605","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1007\/s00018-015-1915-1","article-title":"Critical residues involved in toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharide-binding interface","volume":"72","author":"Lonez","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.plipres.2022.101182_bb0610","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nano.2013.12.003","article-title":"Cationic lipid nanocarriers activate toll-like receptor 2 and NLRP3 inflammasome pathways","volume":"10","author":"Lonez","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.plipres.2022.101182_bb0615","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bbagen.2009.02.015","article-title":"Cationic lipids activate cellular cascades. Which receptors are involved?","volume":"1790","author":"Lonez","year":"2009","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.plipres.2022.101182_bb0620","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2018.08.020","article-title":"Cationic lipids as one-component vaccine adjuvants: a promising alternative to alum","volume":"287","author":"Pizzuto","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.plipres.2022.101182_bb0625","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1089\/hum.1997.8.17-2019","article-title":"Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression","volume":"8","author":"Qin","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.plipres.2022.101182_bb0630","article-title":"Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency","volume":"18","author":"He","year":"2019","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.plipres.2022.101182_bb0635","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nano.2017.10.011","article-title":"Lysine-containing cationic liposomes activate the NLRP3 inflammasome: effect of a spacer between the head group and the hydrophobic moieties of the lipids","volume":"14","author":"Li","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.plipres.2022.101182_bb0640","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2020.06.002","article-title":"Lipid nanoparticles for nucleic acid delivery: current perspectives","volume":"154\u2013155","author":"Samaridou","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.plipres.2022.101182_bb0645","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.plipres.2022.101182_bb0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(03)00056-7","article-title":"Lipid-protein interactions in biological membranes: a structural perspective","volume":"1612","author":"Lee","year":"2003","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782722000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782722000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:55:12Z","timestamp":1778504112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782722000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":130,"alternative-id":["S0163782722000376"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2022.101182","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"Progress in Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plipres.2022.101182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101182"}}